Supplemental Material, Interview_Guide - Facilitators and Barriers Affecting Adherence Among People Living With HIV/AIDS: A Qualitative Perspective

<p>Supplemental Material, Interview_Guide for Facilitators and Barriers Affecting Adherence Among People Living With HIV/AIDS: A Qualitative Perspective by Syed Imran Ahmed, Maryam Farooqui, Syed Azhar Syed Sulaiman, Mohammad Azmi Hassali, and Christopher K. C. Lee in Journal of Patient Experience</p

The flow chart of the study.

<p>Abbreviations:ADR, adverse drug reaction; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; SD, standard deviation; CI, confidence interval.</p

Odd Ratios and Goodness of Fit for Sequential Models of Prediction of an ADR.

<p>Abbreviation: ESRD, end-stage renal disease; GFR, glomerular filtration rate.</p><p>Data are presented as odd ratios (95% confidence interval) unless otherwise specified.</p>a<p>Vascular disease is defined as presence of coronary artery disease or peripheral vascular disease.</p>b<p>Higher values for C statistic and lower values for Akaike Information Criterion indicate better models.</p

Medication most commonly implicated in causing the ADRs.

<p>Abbreviations: ACEIs/ARBs, Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers.</p>a<p>The total number of definite or probable ADRs, n = 62.</p

Regression Coefficient and Score of Each Variable Included in Predictive Model.

<p>Abbreviation: CI, confidence interval; ESRD, end-stage renal disease; OR, odd ratio.</p>a<p>Vascular disease is defined as presence of coronary artery disease or peripheral vascular disease.</p

Comparison of Patients Characteristics According to the Occurrence of an ADR.

<p>Abbreviations: ADR, adverse drug reaction; BP, blood pressure; GFR, glomerular filtration rate; IQR, interquartile range; SD, standard deviation.</p><p>SI conversions: To convert serum creatinine to µmol/L, multiply by 88.4.</p>a<p>Vascular disease is defined as presence of coronary artery disease or peripheral vascular disease.</p

Adverse Drug Reaction (ADR) Rate According to ADR Risk Score Derived From Model 4.

<p>Adverse Drug Reaction (ADR) Rate According to ADR Risk Score Derived From Model 4.</p

Changes in Physical and Mental Component Summary (PCS and MCS) during various stages of treatment.

<p>Changes in Physical and Mental Component Summary (PCS and MCS) during various stages of treatment.</p

General Linear Model Repeated measure ANOVA test for the physical and Mental score in between the subject effect.

<p>General Linear Model Repeated measure ANOVA test for the physical and Mental score in between the subject effect.</p

Taiz and Alhodidah Governance: Difference in estimated marginal mean of MCS.

<p>Taiz and Alhodidah Governance: Difference in estimated marginal mean of MCS.</p